#
Sie müssen Cookies in ihrem Browser aktivieren um diese Website/Applikation in vollem Umfang benutzen zu können.
Sie verwenden einen veralteten Browser mit möglichen Sicherheitsschwachstellen und können nicht alle Funktionen dieser Webseite nutzen.
Hier erfahren Sie, wie einfach Sie Ihren Browser aktualisieren können
+ 43/1/505 86 02 -0
TECH-SUPPORT -888
EDI-CONSULTATION -850
Roche Diagnostics

Roche Diagnostics

The company

Headquartered in Basel, Switzerland, Roche is one of the leading companies in the research-focused health care industry. It combines the strengths of its two business divisions, Pharma and Diagnostics. As one of the world’s largest biotech companies, it develops sophisticated drugs in the areas of oncology, immunology, infectious diseases, ophthalmology and neurosciences. Roche is also one of the world’s major providers of products for in-vitro diagnostics as well as tissue-based cancer tests and a pioneer in the area of diabetes management. Roche has decidedly focused on personalized medicine, which strives to develop drugs and diagnostic procedures designed to decisively improve patient health, quality of live and survival chances. Roche has made this a key point in its business strategy. Since the company’s founding more than a hundred years ago in 1896, Roche has made valuable contributions to world health. The list of essential medicines compiled by the World Health Organization includes 24 drugs developed by Roche, e.g. life-saving antibiotics, malaria drugs and chemotherapeutic drugs.

In 2014, the Roche Group employed 88,500 individuals around the world, invested 8.9 billion Swiss francs in research and development and reached sales of 47.5 billion Swiss francs. The US-based company Genentech is fully owned by the Roche Group. Roche is a majority shareholder of Chugai Pharmaceutical, Japan.

Roche in Austria
In Austria, Roche is among the leading providers of pharmaceutical drugs and products for in-vitro diagnostics. It has a staff of approximately 400 and operates two independent companies in Vienna (sales locations Pharma and Diagnostics). Roche is the undisputed Austrian leader in the hospital market, the cancer drug market as well as the overall in-vitro diagnostics market. In 2007, Roche celebrated its 100 years of business in Austria.

For more information about both subsidiaries, please visit www.roche.at

The challenge

As a supplier to many government agencies including military hospitals, Roche Diagnostics has, since 1 January 2014, been required to issue electronic invoices in the pre-defined ebInterface format to the government. For the implementation of this new federal regulation, Roche Diagnostics wanted to find a solution that could be integrated seamlessly into the existing SAP environment without the need for additional interfaces.

With its expertise in all things SAP and its thorough understanding of the federal government’s requirements, EDITEL made the implementation of this project a breeze. We are very happy with this experience, the level of professionalism of the EDITEL team and, more than anything, with the result!

 

Ernst Linschinger, Senior Project Manager

The solution

The e-Invoice solution by EDITEL fit these requirements like a glove. As a first step, EDITEL analyzed Roche’s SAP environment and checked it against the requirements defined by the federal government, in an effort to ensure that the Roche in-house data format was correctly adapted. Subsequently, the solution was implemented, tested and integrated into the federal government’s test system. The last step was the go live.

The result

Almost 100 percent of all electronic invoices transferred to the federal government were accepted as correct. This ultimately meant that Roche Diagnostics successfully implemented the e-invoicing project to the federal government without the need for additional interfaces and with still no more than a single connection to eXite®. Thanks to the close collaboration and coordination between EDITEL and Roche Diagnostics during all phases of the project, it was implemented swiftly and efficiently.

In short: EDI at Roche Diagnostics

  • EDITEL Services for Roche Diagnostics
    • EDI Communication via eXite®
    • e-Invoice (e-Invoice to the government)
      • Conversion service
      • Process-related consulting for the application and implementation of the federal government’s requirements
  • Benefits thanks to EDI at Roche Diagnostics
    • Swift and efficient compliance with the federal government’s requirements
    • Automated data exchange via the EDI platform eXite®
    • Still no more than one SAP interface needed for all participating partners
    • Status notifications sent directly to the departments in charge
    • Process-related assistance provided by EDITEL during all phases of the project

     

EDITEL Partner Network